4.8 Article

PanDrugs2: prioritizing cancer therapies using integrated individual multi-omics data

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

The coming decade in precision oncology: six riddles

Adam Wahida et al.

Summary: In this Perspective, the authors discuss six key challenges in precision oncology that need to be addressed in order to improve clinical response to molecular targeted therapies. The core principle of precision oncology is that treatment must be personalized, as each cancer has a unique molecular and immune landscape. Choosing the right combination of drugs for each patient and using them at the appropriate stage of the disease is critical to applying precision medicine.

NATURE REVIEWS CANCER (2023)

Article Biology

Patient-specific Boolean models of signalling networks guide personalised treatments

Arnau Montagud et al.

Summary: A mathematical model of prostate cancer was developed to study tumorigenesis and treatment responses, which was personalized using molecular data. The model was validated using clinical data and dose-response data of drugs, demonstrating its predictive power. The findings have important implications for precision oncology.
Article Cell Biology

Systematic illumination of druggable genes in cancer genomes

Junjie Jiang et al.

Summary: By integrating multiple druggable genome resources, researchers identified a group of potential druggable genes and analyzed their expression, genomic alterations, cancer dependencies, and therapeutic potentials. The study revealed a significant number of reliably expressed potential druggable genes in major adult cancers, including some understudied genes, providing new opportunities for cancer treatment.

CELL REPORTS (2022)

Article Oncology

Whole-genome and transcriptome analysis enhances precision cancer treatment options

E. Pleasance et al.

Summary: This study demonstrates the importance of comprehensive whole-genome and transcriptome sequencing and analysis in guiding personalized cancer therapy, resulting in positive clinical benefits for a significant proportion of patients.

ANNALS OF ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

Advancing precision oncology with large, real-world genomics and treatment outcomes data

Ruishan Liu et al.

Summary: An analysis of genomic data and medical records from over 40,000 cancer patients has identified hundreds of mutations that can predict how patients will respond to specific cancer therapies. These predictive biomarkers could provide guidance for personalized treatment planning.

NATURE MEDICINE (2022)

Article Biochemistry & Molecular Biology

Mergeomics 2.0: a web server for multi-omics data integration to elucidate disease networks and predict therapeutics

Jessica Ding et al.

Summary: The Mergeomics web server is a versatile online tool for multi-omics data integration and analysis of disease-related biological pathways, featuring four main functions for correcting marker dependencies, detecting biological processes, examining data consistency, and identifying key regulatory factors.

NUCLEIC ACIDS RESEARCH (2021)

Article Pharmacology & Pharmacy

Pharmacogenomics Clinical Annotation Tool (PharmCAT)

Katrin Sangkuhl et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)

Review Genetics & Heredity

Molecular profiling for precision cancer therapies

Eoghan R. Malone et al.

GENOME MEDICINE (2020)

Article Multidisciplinary Sciences

A user guide for the online exploration and visualization of PCAWG data

Mary J. Goldman et al.

NATURE COMMUNICATIONS (2020)

Editorial Material Oncology

Truly personalized therapy - an end to the era of one size fits all

Nadia Harbeck et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Review Medicine, General & Internal

Big Data in Medicine, the Present and Hopefully the Future

Michela Riba et al.

FRONTIERS IN MEDICINE (2019)

Review Genetics & Heredity

Integrative omics for health and disease

Konrad J. Karczewski et al.

NATURE REVIEWS GENETICS (2018)

Article Biochemistry & Molecular Biology

Defining a Cancer Dependency Map

Aviad Tsherniak et al.